A pharmaceutical distributor has voluntarily recalled packages of Viagra and drugs used to treat depression after a ‘product mix-up’ caused them to be packaged together.
AvKARE announced on Wednesday one lot of sildenafil and one lot of trazodone tablets were ‘inadvertently packaged together during bottling at a 3rd party facility’.
The 100mg sildenafil tablets and the 100mg trazodone tables are being recalled at the consumer level, according to AvKARE’s statement.
Sildenafil is the active ingredient in Viagra, which is used for the treatment of erectile dysfunction and is packaged in 100-count bottles.
AvKARE announced on Wednesday one lot of sildenafil and one lot of trazodone tablets were ‘inadvertently packaged together during bottling at a 3rd part facility’. Both lots (depicted in this chart) are being recalled
Sildenafil is the active ingredient in Viagra, which is used for the treatment of erectile dysfunction and is packaged in 100-count bottles
‘Unintentional consumption of sildenafil may pose serious health risks to consumers with underlying medical issues,’ the company’s statement reads
Trazodone hydrochloride is indicated for the treatment of major depressive disorder and is packaged in 1,000-count bottles.
‘Unintentional consumption of sildenafil may pose serious health risks to consumers with underlying medical issues,’ the company’s statement reads.
For example, sildenafil may interact with nitrates found in some prescription drugs, lowering blood pressure to dangerous levels.
Consumers with diabetes, high blood pressure, or heart disease often take nitrates.
READ RELATED: Platelet-rich plasma: Does the cure for hair loss lie within our blood?
‘Unintended intake of trazodone may result in adverse health consequences such as somnolence/sedation, dizziness, constipation, and blurred vision,’ the company said.
AvKARE said such incidences may be more concerning in elderly patients due to a subsequent increased risk for falls and driving impairment.
Trazodone hydrochloride is indicated for the treatment of major depressive disorder and packaged in 1,000-count bottles
‘Unintended intake of trazodone may result in adverse health consequences such as somnolence/sedation, dizziness, constipation, and blurred vision,’ the company said
‘To date, AvKARE has not received any reports of adverse events related to this recall,’ the company said.
According to a chart shared by AvKARE, the affected lots are: Sildenafil 100mg Tablet, Lot 36884 with an expiration date of 03/2022; and Trazodone Hydrochloride 100mg Tablet, Lot 36783 with an expiration date of 06/2022.
They were distributed to the company’s distributors and wholesalers, and then further distributed nationwide.
‘AvKARE has notified its distributors and customers and is arranging for return of all recalled product of the listed lots,’ the company wrote.
Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using these drug products.
Consumers with questions regarding this recall can contact AvKARE at 1-855-361-3993 Monday- Friday (8am – 4pm CST). This recall is being conducted with the knowledge of the US Food and Drug Administration.
Source: Daily Mail
